Qtick
Sign in

American Express Company (AXP) Competitors & Peers

The 5 largest companies in the same industry as American Express Company, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.

How we identify peers ↗

TickerRelationshipPriceComparables
VCompetitor$423.00P/E 34.3RSI 70Cap 774.0 B
MAPeer$658.84P/E 34.5RSI 66Cap 574.0 B
COFPeer$195.84P/E 12.0RSI 40Cap 121.9 B
PYPLPeer$58.78P/E 11.2RSI 57Cap 51.9 B
SYFPeer$71.70P/E 7.5RSI 51Cap 24.2 B

How these relationships were derived

Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.

Model-inferred relationships (unverified)

Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.

  • GBTGPartner

    American Express is a major shareholder and licenses the 'American Express Global Business Travel' brand to GBTG.

    Model-inferred, unverified — treat as a lead, not evidence
  • DALPartner

    Delta SkyMiles co-brand cards exclusively with AmEx.

    Model-inferred, unverified — treat as a lead, not evidence
  • JPMCompetitor

    AmEx + Chase Sapphire compete in premium cards.

    Model-inferred, unverified — treat as a lead, not evidence
  • MARPartner

    Marriott Bonvoy co-brand cards issued with AmEx (US + EU).

    Model-inferred, unverified — treat as a lead, not evidence
  • HLTPartner

    Hilton Honors co-brand with AmEx.

    Model-inferred, unverified — treat as a lead, not evidence
  • VCompetitor

    Visa + AmEx compete (closed-loop vs open-loop).

    Model-inferred, unverified — treat as a lead, not evidence
  • BREXCompetitor

    Brex + AmEx corporate card overlap.

    Model-inferred, unverified — treat as a lead, not evidence
  • RAMPCompetitor

    Ramp + AmEx corporate-card overlap.

    Model-inferred, unverified — treat as a lead, not evidence